Study analysis · Frontiers in Endocrinology · 2025
Exercise more than 5 hours a week? It might not help you live longer — especially if you're insulin resistant.
If your body struggles to use sugar, 2.5 to 5 hours of exercise a week can cut your risk of dying early by 15%, but doing more than that doesn’t help — and if your insulin resistance is severe, even lots of exercise isn’t enough.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at a huge group of people over many years and found that those who moved more tended to get sick less and live longer — but it didn’t make them move more. So we can’t say moving more causes better health, only that the two are linked.
What’s the bottom line?
If your body has trouble using sugar properly, moving more can help you live longer — but only up to a point.
How strong is this study?
This is a really good observational study because it followed tons of people for a long time and checked their health records carefully. But since people chose their own activity levels, we can’t be 100% sure it was the activity that helped — maybe other things like diet or sleep played a role too.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=299928)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 559 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization. Even though it adjusts for many confounders, residual confounding (e.g., diet, sleep, stress) remains possible. Association does not equal causation.
Key takeaways
- 01
1.
- 02
150–299 minutes of exercise per week lowers death risk by 15% in people with moderate insulin resistance.
- 03
2.
- 04
Insulin resistance raises CVD risk by 72% and death risk by 29%.
- 05
3.
- 06
More than 262 minutes/week doesn't help more for heart disease.
- 07
Yes — getting the recommended amount of exercise (about 30 min/day, 5 days/week) can cut death risk by 15% for people with metabolic issues, but doing double that doesn't help more.
Surprising findings
- More than 600 minutes of exercise per week provided no additional protection against death or heart disease compared to the recommended 150–299 minutes — even for people with insulin resistance.Most public health messaging pushes for 'more is better,' but this massive study shows a hard plateau — pushing beyond 4.5 hours/week doesn’t extend life further, which contradicts elite athlete narratives and fitness culture.
- The protective effect of 150–299 min/week MVPA was only statistically significant for all-cause mortality in those with moderate insulin resistance — not for those with low or severe resistance.It’s counterintuitive that moderate insulin resistance benefits most from exercise — not the mildly insulin sensitive or the severely resistant. This suggests a 'Goldilocks zone' where exercise works best.
Practical takeaways
Aim for 150–299 minutes of moderate-to-vigorous exercise per week (e.g., brisk walking, cycling, or jogging) — that’s 30–45 minutes, 5 days a week — especially if you have a large waist, high triglycerides, or elevated fasting blood sugar.
This doesn’t mean exercise is useless beyond that — it still benefits mental health, strength, and mobility — just not mortality risk beyond the plateau.
high confidenceIf you have a waist-to-height ratio over 0.5 and high triglycerides, ask your doctor for a TyG-WHtR calculation — it’s a simple, cheap way to assess hidden metabolic risk.
TyG-WHtR is a surrogate marker — not a direct measure of insulin resistance — so it should be used alongside other clinical data.
medium confidenceIf you have severe insulin resistance (high TyG-WHtR), don’t rely on exercise alone — combine it with dietary changes, sleep optimization, and medical guidance.
The study is observational — it shows association, not causation. Randomized trials are needed to confirm these effects.
medium confidenceWhy this study matters
The Sweet Spot for Exercise
The study found that 150–299 minutes of moderate-to-vigorous exercise per week (about 30–45 minutes a day, 5 days a week) reduced all-cause mortality risk by 15% in people with moderate insulin resistance. Beyond 262 minutes/week for heart disease and 217 minutes/week for overall death risk, extra exercise offered no additional benefit.
Most people think 'more exercise = better health,' but this shows there’s a ceiling — pushing past 4.5 hours a week won’t make you live longer, even if you’re metabolically unhealthy.
Insulin Resistance Is a Silent Killer
Elevated TyG-WHtR — a marker combining waist size, triglycerides, and fasting blood sugar — was linked to a 72% higher risk of cardiovascular disease and a 29% higher risk of dying early, even in people without prior heart disease.
You can feel fine but still have dangerous metabolic dysfunction. This isn’t about being overweight — it’s about hidden metabolic damage that shows up before symptoms do.
Exercise Can’t Fix Severe Insulin Resistance
Even among people who met or exceeded the recommended 150+ minutes of weekly exercise, those with severe insulin resistance (TyG-WHtR tertile 3) still had significantly higher mortality risk — meaning exercise alone isn’t enough to overcome extreme metabolic dysfunction.
This shatters the myth that 'just move more' solves all metabolic problems. For some, diet, medication, or medical intervention may be non-negotiable.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
If your body has trouble using sugar properly, moving more can help you live longer — but only up to a point.
Research results
1. 150–299 minutes of exercise per week lowers death risk by 15% in people with moderate insulin resistance. 2. Insulin resistance raises CVD risk by 72% and death risk by 29%. 3. More than 262 minutes/week doesn't help more for heart disease.
What this means - more context
Yes — getting the recommended amount of exercise (about 30 min/day, 5 days/week) can cut death risk by 15% for people with metabolic issues, but doing double that doesn't help more.
To determine whether different levels of moderate-to-vigorous physical activity (MVPA) modify the associations between insulin resistance (measured by TyG-WHtR index) and risks of cardiovascular disease (CVD) and all-cause mortality.
Among 299,928 adults without prevalent CVD, higher MVPA was associated with reduced CVD and mortality risk, with optimal benefits plateauing at 262 min/week for CVD and 217 min/week for mortality. Elevated TyG-WHtR significantly increased CVD and mortality risk. MVPA at 150–299 min/week reduced all-cause mortality risk specifically in those with moderate insulin resistance, but higher MVPA (≥600 min/week) offered no additional benefit. Severe insulin resistance remained linked to higher mortality even with adequate MVPA.
Methods Used
Cohort study of 299,928 adults from UK Biobank with no prevalent CVD at baseline; MVPA and TyG-WHtR were measured at baseline; Cox proportional hazards models assessed independent and joint associations with incident CVD and all-cause mortality over median follow-up of 13.6–13.8 years.
Main Finding
MVPA of 150–299 min/week was associated with a 15% lower all-cause mortality risk (HR 0.85) in individuals with moderate insulin resistance (TyG-WHtR 7.01–8.03); elevated TyG-WHtR was associated with a 72% higher CVD risk and 29% higher all-cause mortality risk; MVPA beyond 262 min/week provided no further CVD risk reduction.
Confidence Level
High — large sample size, long follow-up, adjusted for covariates, effect sizes and confidence intervals reported, use of validated surrogate for insulin resistance.
Study Flags
Red Flags
- •Residual confounding possible despite adjustments
- •MVPA measured by self-report, not objective devices
- •TyG-WHtR is a surrogate marker, not direct insulin resistance measurement
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
More than 600 minutes of exercise per week provided no additional protection against death or heart disease compared to the recommended 150–299 minutes — even for people with insulin resistance.
Most public health messaging pushes for 'more is better,' but this massive study shows a hard plateau — pushing beyond 4.5 hours/week doesn’t extend life further, which contradicts elite athlete narratives and fitness culture.
Practical Takeaways
Aim for 150–299 minutes of moderate-to-vigorous exercise per week (e.g., brisk walking, cycling, or jogging) — that’s 30–45 minutes, 5 days a week — especially if you have a large waist, high triglycerides, or elevated fasting blood sugar.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 559 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study looked at a huge group of people over many years and found that those who moved more tended to get sick less and live longer — but it didn’t make them move more. So we can’t say moving more causes better health, only that the two are linked.
Strengths
- Very large sample size (n=299,928)
- Long follow-up (median 13.6–13.8 years)
- Prospective design with objective outcome ascertainment (hospital/death registries)
Weaknesses
- Observational design — no randomization
- Blinding status unknown — irrelevant for cohort, but confirms non-experimental nature
- Self-reported physical activity — prone to recall/social desirability bias
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
If your body has trouble using sugar properly, moving more can help you live longer — but only up to a point.
Research results
1. 150–299 minutes of exercise per week lowers death risk by 15% in people with moderate insulin resistance. 2. Insulin resistance raises CVD risk by 72% and death risk by 29%. 3. More than 262 minutes/week doesn't help more for heart disease.
What this means - more context
Yes — getting the recommended amount of exercise (about 30 min/day, 5 days/week) can cut death risk by 15% for people with metabolic issues, but doing double that doesn't help more.
To determine whether different levels of moderate-to-vigorous physical activity (MVPA) modify the associations between insulin resistance (measured by TyG-WHtR index) and risks of cardiovascular disease (CVD) and all-cause mortality.
Among 299,928 adults without prevalent CVD, higher MVPA was associated with reduced CVD and mortality risk, with optimal benefits plateauing at 262 min/week for CVD and 217 min/week for mortality. Elevated TyG-WHtR significantly increased CVD and mortality risk. MVPA at 150–299 min/week reduced all-cause mortality risk specifically in those with moderate insulin resistance, but higher MVPA (≥600 min/week) offered no additional benefit. Severe insulin resistance remained linked to higher mortality even with adequate MVPA.
Methods Used
Cohort study of 299,928 adults from UK Biobank with no prevalent CVD at baseline; MVPA and TyG-WHtR were measured at baseline; Cox proportional hazards models assessed independent and joint associations with incident CVD and all-cause mortality over median follow-up of 13.6–13.8 years.
Main Finding
MVPA of 150–299 min/week was associated with a 15% lower all-cause mortality risk (HR 0.85) in individuals with moderate insulin resistance (TyG-WHtR 7.01–8.03); elevated TyG-WHtR was associated with a 72% higher CVD risk and 29% higher all-cause mortality risk; MVPA beyond 262 min/week provided no further CVD risk reduction.
Confidence Level
High — large sample size, long follow-up, adjusted for covariates, effect sizes and confidence intervals reported, use of validated surrogate for insulin resistance.
Study Flags
Red Flags
- •Residual confounding possible despite adjustments
- •MVPA measured by self-report, not objective devices
- •TyG-WHtR is a surrogate marker, not direct insulin resistance measurement
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
More than 600 minutes of exercise per week provided no additional protection against death or heart disease compared to the recommended 150–299 minutes — even for people with insulin resistance.
Most public health messaging pushes for 'more is better,' but this massive study shows a hard plateau — pushing beyond 4.5 hours/week doesn’t extend life further, which contradicts elite athlete narratives and fitness culture.
Practical Takeaways
Aim for 150–299 minutes of moderate-to-vigorous exercise per week (e.g., brisk walking, cycling, or jogging) — that’s 30–45 minutes, 5 days a week — especially if you have a large waist, high triglycerides, or elevated fasting blood sugar.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 559 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study looked at a huge group of people over many years and found that those who moved more tended to get sick less and live longer — but it didn’t make them move more. So we can’t say moving more causes better health, only that the two are linked.
Strengths
- Very large sample size (n=299,928)
- Long follow-up (median 13.6–13.8 years)
- Prospective design with objective outcome ascertainment (hospital/death registries)
Weaknesses
- Observational design — no randomization
- Blinding status unknown — irrelevant for cohort, but confirms non-experimental nature
- Self-reported physical activity — prone to recall/social desirability bias
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This is a really good observational study because it followed tons of people for a long time and checked their health records carefully. But since people chose their own activity levels, we can’t be 100% sure it was the activity that helped — maybe other things like diet or sleep played a role too.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=299928)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 559 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization. Even though it adjusts for many confounders, residual confounding (e.g., diet, sleep, stress) remains possible. Association does not equal causation.